Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Insect Cell Culture Market: By Product Type, By Application and Region Forecast 2020-2031
Insect Cell Culture Market: By Product Type, By Application and Region Forecast 2020-2031
Insect cell culture Market size was valued at US$ 2.1 billion in 2024 and is expected to reach US$ 3.7 billion by 2031, growing at a significant CAGR of 8.80% from 2025-2031. The cultivation of insect cell lines and organs for the proliferation of entomopathogenic viruses. They are also used in for the production of recombinant proteins, due to their ability of quick multiplication of cells and protein modification. The development of genetic engineering, recombinant DNA technology, and genomic and proteomic profiling have increased the demand of cell media. In May 2018, GE Healthcare Life Sciences announced that company is increasing its annual cell culture media capacity by tenfold in its facility in Pasching, Austria.
Study Period
2025-2031Base Year
2024CAGR
8.8%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Increasing incidence of chronic diseases such as cancer, rise in awareness on the latest trends in cell culture technology are the major factors driving the growth of the market over the forecasted period. In addition, increase in the use of insect media as a research tool in academic and industrial research center, government support and regulatory approvals for cell cultured vaccines expected to offer significant growth for the insect cell culture market. However, stringent regulatory policies are expected the hinder the growth of the insect cell culture market in the forecasted years
Geographically, global insect cell culture market is widespread into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is the dominating the market share of the market due to the increasing regulatory approvals for cell cultured based vaccines and increasing incidence of chronic diseases such as cancer. Europe is expected to show significant growth in the market. Asia pacific market is expected to show moderate growth over the forecasted period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 2.1 billion |
|
Market Size in 2031 |
US$ 3.7 billion |
|
Market CAGR |
8.8% |
|
By Product type |
|
|
By Application type |
|
|
By Region |
|
Download Free Sample Report
The insect cell culture market size was valued at US$ 2.1 billion in 2024 and is expected to reach US$ 3.7 billion by 2031, growing at a significant CAGR of 8.80% from 2025-2031
The market key players are: Life Technologies Corning (Cellgro) Sigma-Aldrich Thermo Fisher Merck Millipore GE Healthcare Lonza BD HiMedia Takara CellGenix Atlanta Biologicals PromoCell
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Insect Cell Culture Market Introduction |
| 2.1.Global Insect Cell Culture Market - Taxonomy |
| 2.2.Global Insect Cell Culture Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application type |
| 2.2.3.Region |
| 3. Global Insect Cell Culture Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Insect Cell Culture Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Insect Cell Culture Market By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Classical Media & Salts |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Serum-free Media |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Stem Cell Media |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Insect Cell Culture Market By Application type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Biopharmaceutical Manufacturing |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Drug Screening and Development |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Tissue Culture & Engineering |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Gene Therapy |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Cytogenetic |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Insect Cell Culture Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Insect Cell Culture Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Classical Media & Salts |
| 8.1.2.Serum-free Media |
| 8.1.3.Stem Cell Media |
| 8.2. Application type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Biopharmaceutical Manufacturing |
| 8.2.2.Drug Screening and Development |
| 8.2.3.Tissue Culture & Engineering |
| 8.2.4.Gene Therapy |
| 8.2.5.Cytogenetic |
| 8.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Insect Cell Culture Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Classical Media & Salts |
| 9.1.2.Serum-free Media |
| 9.1.3.Stem Cell Media |
| 9.2. Application type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Biopharmaceutical Manufacturing |
| 9.2.2.Drug Screening and Development |
| 9.2.3.Tissue Culture & Engineering |
| 9.2.4.Gene Therapy |
| 9.2.5.Cytogenetic |
| 9.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Insect Cell Culture Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Classical Media & Salts |
| 10.1.2.Serum-free Media |
| 10.1.3.Stem Cell Media |
| 10.2. Application type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Biopharmaceutical Manufacturing |
| 10.2.2.Drug Screening and Development |
| 10.2.3.Tissue Culture & Engineering |
| 10.2.4.Gene Therapy |
| 10.2.5.Cytogenetic |
| 10.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Insect Cell Culture Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Classical Media & Salts |
| 11.1.2.Serum-free Media |
| 11.1.3.Stem Cell Media |
| 11.2. Application type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Biopharmaceutical Manufacturing |
| 11.2.2.Drug Screening and Development |
| 11.2.3.Tissue Culture & Engineering |
| 11.2.4.Gene Therapy |
| 11.2.5.Cytogenetic |
| 11.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Insect Cell Culture Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Classical Media & Salts |
| 12.1.2.Serum-free Media |
| 12.1.3.Stem Cell Media |
| 12.2. Application type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Biopharmaceutical Manufacturing |
| 12.2.2.Drug Screening and Development |
| 12.2.3.Tissue Culture & Engineering |
| 12.2.4.Gene Therapy |
| 12.2.5.Cytogenetic |
| 12.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Life Technologies |
| 13.2.2.Corning (Cellgro) |
| 13.2.3.Sigma-Aldrich |
| 13.2.4.Thermo Fisher |
| 13.2.5.Merck Millipore |
| 13.2.6.GE Healthcare |
| 13.2.7.Lonza |
| 13.2.8.BD |
| 13.2.9.HiMedia |
| 13.2.10.Takara |
| 13.2.11.CellGenix |
| 13.2.12.Atlanta Biologicals |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.